Search for: "Wyeth Inc"
Results 1 - 20 of 319
Sorted by Relevance | Sort by Date
20 Oct 11:11 am
Oral argument argued before the Eighth Circuit U.S. Court of Appeals on or about 10-20-2009
13 Nov, 2008 1:52 pm
... of Torts §402A (1965). The seminal case, Greenman v. Yuba Power Products, Inc., explained the rationale for what it called "strict
liability": We need not recanvass the reasons for ... drive New Baby around. To replace it, he buys a hybrid made by Minigas, Inc. to drive to
work. Wife puts New Baby's carseat in the front seat, ... encounter it for the first time. First impressions are important. Now, back to Conte. Why was Wyeth's liability at issue at all? Because the plaintiff had no warning causation ...
21 Jan 5:15 am
In Conte v. Wyeth, a California appellate court held that the manufacturer of a brand name drug could potentially be held liable for an injury
allegedly caused by the generic version of the drug. Our earlier rant about that ... review the appellate court decision. Although we can't yet locate the order on the California
Supreme Court website, counsel in the case received the following e-mail notice: CONTE v. WYETH, INC.
Case: S169116, Supreme Court of California Date (YYYY-MM-DD): 2009-01-21 Event ...
16 Feb 9:59 am
The recent opinion of the Seventh Circuit in Giles v. Wyeth, Inc., 2009 WL 331290 (7th Cir. 2009),
provides me with the opportunity to discuss a couple of interesting aspects of Federal Rule of Evidence 407, the subsequent remedial measure...
25 Jan 2:36 pm
... said people with knowledge of those banks' roles. Morgan Stanley and Evercore Partners Inc. are counseling Wyeth, the people said. Pfizer spokesman Ray Kerins and ... contend its hormone replacement drugs Prempro and Premarin cause breast cancer. Wyeth has also set aside $21 billion to resolve a decade of litigation over ... than Pfizer is right now. It's a company in restructuring acquiring a company
in restructuring." Wyeth also has "plenty of lingering legal and patent expiration problems of its own ...
20 Sep, 2007 10:05 pm
... denied Baltimore-based Lupin Pharmaceuticals, Inc.'s (LPI) motion to dismiss an action against it and its parent, Mumbai, India-based Lupin
Ltd. (Lupin), brought by pharmaceutical giant Wyeth. In reaching its decision, the District Court concluded that "when a wholly-owned U.S.
subsidiary of a foreign corporation ... ® in the U.S. Under the Hatch-Waxman Act, the filing of an ANDA is an act of infringement. Accordingly, Wyeth, which owns U.S. Patents 6,274,171; 6,403,120; and 6, ...
26 Jan 12:47 am
... litigation charges and that it would cut a further 10% of its work force, while Wyeth also reported a decline in fourth-quarter net profit.
Pfizer is in talks to acquire ... after the takeover, according to one person close to the deal. That would put control of Wyeth firmly in the
hands of Pfizer Chief Executive Jeffrey B. Kindler, who took Pfizer ... amp; Co. Barclays PLC and Citigroup Inc. acted as financial advisers.
Meanwhile, Crucell NV said Wyeth pulled out of friendly takeover talks with the Dutch ...
29 May, 2008 10:00 am
... a similar CBE-based anti-preemption argument. Anyway, Wyeth has an additional arrow in its quiver - the Supreme Court's holding earlier
this year in Riegel v. Medtronic, Inc., rejecting the contention that manufacturers had broad discretion to make ... has violated a state-law
obligation." 129 S. Ct. at 1008. After finishing with its preemption by impossibility argument, Wyeth goes on to make the more conventional
preemption by obstruction argument that prevailed in Geier v. American Honda Motor Co., ...
4 Mar 12:25 pm
... violation. (Click here for that opinion; here for the WSJ story.) In the second case, issued in December, Altria Group Inc. v. Good, the
Court ruled 5-4 that a group of Maine consumers could continue with its suit against Altria ... it's "a central premise of federal drug regulation" that "the manufacturer bears
responsibility for the content of its label at all times. Wyeth's second major argument is that concurrent state liability would frustrate the
purpose and objective of federal regulation, ...
6 Jul 1:03 pm
... touchstone in every pre-emption case.' " Slip Op. at 8. citing Medtronic, Inc. v. Lohr, 518 U.S. 470, 485 (1996) (internal quotation ...
FDA "new drug" evaluation package. Slip Op. at 9-10. Regarding Wyeth's first pre-emption argument, the majority emphasized that re-labeling the
drug ... approved by the FDA prior to being placed on the market, and clinical trials are generally required. The Wyeth decision clearly
emphasizes that drug manufacturers are responsible for ensuring that warning labels are up ...
3 Feb 1:40 am
Pfizer Inc.'s Wyeth acquisition perverts the U.S. government's Troubled Asset Relief Program, relying
on loans from five banks aided by the bailout for a deal that ... Department's antitrust division asks the government to block the deal unless Pfizer and Wyeth agree to sell medicines in the U.S. at no more than the lowest price they ... down forever," Funtleyder said. Two Lawsuits The acquisition prompted two
lawsuits from Wyeth shareholders who said their board should have held out for a better price. ...
24 Jan 5:37 am
... Miriam Hill Inquirer Staff Writer A $60 billion purchase of drugmaker Wyeth by rival Pfizer Inc.
is not a certainty, but if it does happen, it could lead ... companies, these analysts said. Cuts likely would fall more heavily on Wyeth,
which employs 47,000 people worldwide, 5,000 at facilities in Malvern ... work was Bob Sliskovic, a scientist credited with developing Lipitor. Rumors of a Pfizer acquisition of
Wyeth or another company have been circulating for months. The Wall Street Journal confirmed ...
28 Jan 3:15 am
... another's misery. What's to become of Wyeth's 300+ legal department? According to an article by The Legal Intelligencer, Pfizer
Inc. has made no secret of its intentions ... good thing," the source said, is that for a merger of this size, there is "remarkably little
overlap." Wyeth, for example, has vaccine and biopharmaceutical departments that Pfizer doesn't have ... 30% reduction in legal staff (January
29, 2001 Honeywell - Allied Signal Inc.: reduced lawyer count by 50% (December 1, 1999) If you do ...
23 Nov 12:33 pm
... , the Illinois woman took Prempro for 5 years before she developed breast cancer in 2002. So far, Pfizer's Wyeth unit has lost 5 of the 8
cases tried with 33 more scheduled for trial. As we have all seen, ... thought to cause health problems include birth control drugs, Yaz and Yasmin which were manufactured by Bayer
Healthcare Pharmaceuticals, Inc. The Georgia Injury lawyers at Finch McCranie, LLP[www.georgiainjurylawyers.net] have pursued prescription drug
injury cases and other personal injury ...
29 Oct, 2008 12:00 pm
... injection, but instead chose to preserve the added effectiveness of intravenous administration. . .by requiring Wyeth to include carefully
tailored warnings and instructions on the drug's labeling. . . . In this case, ... ll tell you so. Our coverage of the defense side in Levine is as follows: Wyeth's original petition for certiorari is here, and you can find our ... buying such tripe. The Court rejected that argument in Cipollone v. Liggett Group,
Inc., 505 U.S. 505, 521-22 (1992), and ignored the same ...
30 Sep 12:29 am
... her. Jurors deliberated about two hours and 15 minutes before concluding that Wyeth's drug was a proximate cause of Connie Barton's breast
cancer. Barton, ... she began taking Prempro to treat menopausal symptoms. Jurors will hear arguments on Wyeth's liability and possible
punitive damages at a second phase of the trial starting ... t necessarily bar lawsuits under state law. The case is Barton v. Wyeth
Pharmaceuticals Inc., 040406301, Court of Common Pleas, Philadelphia County, Pennsylvania. If you ...
20 Mar 6:00 am
Reyes v. Wyeth Pharmaceuticals, Inc., 2009 WL 661393 (D.P.R. Mar. 9, 2009) Martha Reyes created a
glass sculpture titled "Watcher of the Fire." Reyes lent the sculpture to Cordero, one of the ... that he would photograph the work. Reyes had never exhibited the sculpture or offered
it for sale. Cordero, unbenounced to Reyes, offered the sculpture to Wyeth, Amgen and ERC Communications for use in a publicity campaign. ERC
drafted an advertisement that contained the work, which ran in ...
5 May 5:57 am
... court in state court in Houston April 14 revived a suit brought against Wyeth by a woman who said her breast cancer was caused by the
menopause medicine Prempro. Three ... Glaxo over Paxil and one against New York-based Pfizer Inc. over Zoloft. Drugmakers have not given up on
preemption in every case ... approval of the label. Seroquel, the target of suits because of its links to diabetes, is not covered by the Wyeth
ruling because the FDA mandated that drugmakers add a classwide warning for all atypical ...
9 Jun 9:54 am
... tam lawsuits filed against them in federal court in Massachusetts. Pharma giant, Wyeth - poised to be bought out by large pharmaceutical
company Pfizer, Inc. later this year - is being accused of overcharging state Medicaid programs by failing to ... drugs than they should have."
By failing to offer Medicaid programs the best price for Protonix, it is alleged that Wyeth avoided paying hundreds of millions of dollars in
rebates. The presence of two whistleblowers in the two lawsuits suggests that ...
16 May, 2007 10:34 am
... liability case to go to trial, Simon v. Wyeth (040604229, Philadelphia Court of Common Pleas), as reported by Jef Feeley and Sophia Pearson
in their Bloomberg.com article: A Pfizer Inc. unit failed to properly warn a New Jersey ... menopausal women combined Premarin, which contained
estrogen, with Provera, which contains progestin, to relieve their symptoms. In 1996, Wyeth combined the two substances in its Prempro pill.
The Simon case was one of at least 5,000 lawsuits pending against Wyeth over ...
Search on: Blawgs.FM | BlawgSearch Google Co-op | Blawg.com | Bloglines | Feedster | Google Blog Search | Technorati | Google | MSN | Yahoo!